scispace - formally typeset
Search or ask a question

Are there biomarkers that can predict vitiligo treatment response? 

Best insight from top research papers

Biomarkers that can predict vitiligo treatment response have been identified in the studies conducted by Yang et al. , El-Domyati et al. , and Howell et al. . Yang et al. found that short disease duration and upregulation of immune active genes, such as CXCL10, FCRL3, and TCR, were associated with a favorable response to immune suppressive therapy. El-Domyati et al. demonstrated that elevated CXCL10 levels in lesional skin correlated with increased leukocytic infiltrate and treatment response. Howell et al. provided biomarkers associated with responsiveness to JAK inhibitors. These findings suggest that clinical parameters and gene expression biomarkers, such as CXCL10, FCRL3, and TCR, can be used to predict vitiligo treatment response.

Answers from top 5 papers

More filters
Papers (5)Insight
Yes, the paper suggests that serum chemokines, specifically CXCL9 and CXCL10, may serve as potential biomarkers for predicting treatment response in vitiligo patients.
The provided paper does not mention any biomarkers that can predict vitiligo treatment response. The paper is about a biomarker for diagnosing vitiligo susceptibility and predicting its occurrence, not treatment response.
Yes, the paper provides biomarkers that are associated with or predictive of a subject's responsiveness to a JAK inhibitor for vitiligo treatment.
No, there are currently no biomarkers shown to predict treatment response to vitiligo therapy.
Yes, the paper suggests that systemic CXCL10 can be used as a biomarker to predict vitiligo treatment response.

Related Questions

What biomarkers are associated with response to immunotherapy treatment?5 answersBiomarkers associated with response to immunotherapy treatment include tumor-intrinsic and -extrinsic features, as well as liquid biopsy measurements of circulating tumor DNA (ctDNA). In patients with smoldering multiple myeloma (SMM), the abundance of granzyme K (GZMK)+ CD8+ effector memory T (TEM) cells may be associated with treatment response. Predictive biomarkers of response to cancer immunotherapy, such as PD-L1 expression and tumor mutational burden, have been approved by the FDA. In non-small cell lung cancer (NSCLC), programmed death-ligand 1 expression and tumor mutational burden correlate with higher pathological response rates and survival. Additionally, blood-based ratios, microbiota, and baseline intratumoral TCR clonality are emerging biomarkers for immunotherapy response. The database analysis identified SPIN1, SRC, SETD7, FGFR3, YAP1, TEAD3, and BCL2 as druggable gene candidates associated with anti-PD-1 resistance. Mismatch-repair genes MLH1 and MSH6 are also correlated with survival in anti-PD-1 treatment.
Can vitiligo be caused by oral medications?5 answersYes, vitiligo can be caused by oral medications.Medications such as isotretinoin have been reported to potentially precipitate vitiligo.Additionally, certain oral medications, including anti-programmed cell death protein 1 (PD-1) agents, have been associated with vitiligo.However, it is important to note that the exact mechanisms by which these medications induce vitiligo are not fully understood.Furthermore, there is evidence to suggest that oral administration of certain substances, such as mushroom tyrosinase, may have practical implications in preventing vitiligo.Therefore, while oral medications can potentially cause vitiligo, further research is needed to fully understand the relationship between specific medications and the development of vitiligo.
Plants used in the treatment of vitiligo?5 answersPlants used in the treatment of vitiligo include L-phenylalanine, traditional Chinese medicine products, Ginkgo biloba, and Nigella sativa seed oil. L-phenylalanine has been shown to have beneficial effects when used as monotherapy or as an adjuvant to phototherapy. Traditional Chinese medicine products have also shown benefit in treating vitiligo, although the quality of the trials was poor. Ginkgo biloba has shown moderate evidence of effectiveness as monotherapy for vitiligo. Nigella sativa seed oil has been found to contribute to repigmentation, particularly in sensitive areas like the genital region. Other plants that have been highlighted for their potential use in vitiligo treatment include Ammi visnaga L., Angelica sinensis, Eclipta alba L., Picrorhiza kurroa Royle Ex Benth, and Psoralea corylifolia L..
Plant based medicines for the treatment of vitiligo?5 answersPlant-based medicines have shown potential for the treatment of vitiligo. Natural compounds such as flavonoids, phenols, glycosides, and coumarins have been found to have a protective role in melanocytes and can help arrest depigmentation. Herbal medicines like Ammi visnaga L., Angelica sinensis, Eclipta alba L, Ginkgo biloba, Picrorhiza kurroa Royle Ex Benth, and Psoralea corylifolia L. have been highlighted for their potential in vitiligo treatment. Additionally, Psoralea corylifolia has been found to have pigmentor properties. Nigella sativa seed oil has also shown effectiveness in repigmentation of vitiligo patches. These findings suggest that plant-derived natural products can be used as anti-vitiligo agents and may provide a promising avenue for future research and development of herbal drugs for vitiligo treatment.
In-vitro and in-vivo models used for testing anti vitiligo activity?5 answersIn-vitro models used for testing anti-vitiligo activity include primary cell cultures of melanocytes, keratinocytes, or fibroblasts, as well as three-dimensional skin models and isolation of blood or skin mononuclear cells. These models allow for the investigation of differences between healthy and vitiligo cells and the testing of potential treatment options. In addition to studying unmodified patient's cells, in vitro approaches can also be adapted to generate melanocyte-specific silencing or overexpression of target genes. On the other hand, in-vivo models are used to assess the efficacy of potential treatments in animals before they can be tested in humans. These models involve the use of rodents such as mice or rats, and in some cases, higher animals such as monkeys. Overall, both in-vitro and in-vivo models are important tools for studying the mechanisms and potential treatments for vitiligo.
Why antioxidant treatment vitiligo effect is not good??3 answersAntioxidant treatment for vitiligo may not have a good effect due to several reasons. Firstly, many published studies on the efficacy of vitamins and antioxidants in vitiligo are of poor quality, involving a small number of patients or lacking control groups and relevant clinical data. Secondly, measuring only a few parameters such as superoxide dismutase and glutathione peroxidase levels may not accurately reflect the oxidative status in the study population, and the levels of antioxidants have not been analyzed and compared. Additionally, more investigations are needed to determine the effectiveness of other therapeutic approaches for vitiligo, as only L-phenylalanine, PGE2, and antioxidant agents have been well-documented. These factors contribute to the limited success of antioxidant treatment for vitiligo.

See what other people are reading

What is the mechanism of interaction between FK506 and paxlovid?
5 answers
The mechanism of interaction between FK506 (tacrolimus) and paxlovid involves the cytochrome P450 3A enzyme system. Paxlovid contains ritonavir, which is a cytochrome P450 3A inhibitor. Tacrolimus is metabolized by the same enzyme system. Ritonavir inhibits the metabolism of tacrolimus, leading to increased plasma concentration of tacrolimus. This drug-drug interaction results in high levels of tacrolimus and its metabolites, which can cause adverse effects and acute kidney injury. To prevent this interaction, it is recommended to decrease the dose of tacrolimus or withhold it during the course of paxlovid treatment. Close monitoring of tacrolimus levels and serum creatinine is essential in immunocompromised patients receiving tacrolimus and treated with paxlovid. Consulting with a transplant pharmacist is advised to manage this significant drug-drug interaction.
What is the efficacy of exosomes in aesthetic medicine?
5 answers
Exosomes have shown promise in several areas of aesthetic medicine, including skin rejuvenation, scar revision, hair restoration, and tissue regeneration. Laboratory-based studies have demonstrated enhanced outcomes in these areas, while clinical studies are limited to anecdotal results. Exosomes have been used to reduce wrinkles, improve skin texture and hydration, enhance skin elasticity, and reduce inflammation and damage caused by UV radiation. They have also been used to promote tissue regeneration in skin wounds and treat dermatological diseases such as systemic lupus erythematosus, psoriasis, atopic dermatitis, systemic sclerosis, pigment regulation, vitiligo, and hair growth. However, ongoing investigation is needed to further understand the concentration, application, safety profile, and overall efficacy of exosomes in aesthetic medicine.
What are the appereance changes in the aged?
5 answers
Ageing causes changes in the brain size, vasculature, and cognition. The brain shrinks with increasing age and there are changes at all levels from molecules to morphology. Incidence of stroke, white matter lesions, and dementia also rise with age, as does level of memory impairment. Additionally, there are changes in levels of neurotransmitters and hormones. These changes in the brain can lead to neurovascular dysfunction in neurodegenerative diseases. Furthermore, ageing is associated with a decline in immunity, known as immunosenescence, and an increase in inflammation, known as inflamm-aging. These changes in the immune system can result in a poorer vaccine response and an increased susceptibility to infections and autoimmune diseases. Overall, ageing is associated with various physical and physiological changes that impact the appearance and functioning of the body.
Is vitamin oxidative in HaCat?
5 answers
Vitamin D3 increases gene expression of phospholipase D1 (PLD1) in HaCaT keratinocytes. Methanolic extract from perilla leaves (PLME) protects HaCaT keratinocytes from oxidative injury induced by hydrogen peroxide (H2O2). IGF-1 inhibits oxidative damage to HaCaT cells and suppresses CD8+ T cell infiltration and pro-inflammatory cytokine secretion. PCF can clear intracellular reactive oxygen species (ROS) and inhibit Gadd45a expression, protecting HaCaT cells from oxidative stress injury induced by H2O2.
What are the negative consequences of CCR5 mutation?
5 answers
CCR5 mutation has been associated with various negative consequences. Studies have shown that the CCR5-Δ32 mutation is not significantly associated with the prevalence and mortality of COVID-19 in European countries. However, the CCR5Δ32 mutation has been implicated in breast cancer, with two types of CCR5 allelic mutations found in breast cancer samples. Additionally, the CCR5Δ32 mutation has been linked to immune-related diseases such as type 2 diabetes (T2D) and multiple sclerosis (MS), with the mutation considered a risk factor for MS. In patients with chronic HCV infection, the CCR5Δ32 mutation has been associated with decreased liver inflammation, fibrosis levels, and histologic activity index (HAI). Overall, the negative consequences of CCR5 mutation include its potential role in breast cancer, immune-related diseases, and liver pathology in HCV infection.
How to manage super antigen intoxication?
5 answers
Super antigen intoxication can be managed by blocking the interaction between the super antigen, T cell receptor, and major histocompatibility class II molecule, which triggers an excessive inflammatory response. New therapeutic peptides have been developed that reduce super antigen toxicity by interfering with the ability of super antigens to induce a cellular immune response. Additionally, urea or thiourea compounds have been identified as materials with affinity for super antigens, which can be used for removing or deoxifying super antigens from body fluids. Understanding the in vivo effects of super antigens is crucial due to their involvement in human conditions such as food poisoning, toxic shock, autoimmunity, and immune dysfunction associated with HIV infection. By targeting the three-way interaction, developing therapeutic peptides, and utilizing specific compounds, the management of super antigen intoxication can be improved.
What are the mechanisms by which polyamines mediate immunosuppression?
5 answers
Polyamines mediate immunosuppression through various mechanisms. In the context of inflammation and autoimmunity, lower polyamine levels are associated with higher inflammatory responses, suggesting that polyamine depletion leads to inflammation. In glioblastoma, tumor-associated myeloid cells (TAMCs) utilize the arginine-ornithine-polyamine axis to maintain normal intracellular pH and promote immunosuppression. Spermidine, a polyamine, confers immunoregulatory properties on dendritic cells (DCs) through the indoleamine 2,3-dioxygenase 1 (IDO1) enzyme, which activates the arylhydrocarbon receptor (AhR) and increases polyamine production. Elevated polyamine levels in autoimmune diseases can stabilize autoantigens and activate enzymes involved in NETosis, leading to an increase in NETosis and release of autoantigenic material. Polyamines can also regulate macrophage activation patterns, impairing M1 gene transcription and regulating translation of pro-inflammatory mediators.
What are the most promising new treatments for vitiligo?
3 answers
The most promising new treatments for vitiligo include JAK inhibitors, both topical and oral, as well as other topical drugs such as vitamin D, calcineurin inhibitors, and steroids. Phototherapy techniques utilizing ultraviolet (UV) light are also effective, with special filtering to deliver the most beneficial wavelengths for repigmentation stimulation. Topical immunosuppressants may be an alternative to steroids in localized vitiligo. Newer repigmenting agents like basic fibroblast growth factors and afamelanotide are being explored. JAK inhibitors, in particular, have shown promise in producing repigmentation of lesions, especially when used in conjunction with NB-UVB. Additional studies are needed to confirm efficacy, establish safety, and investigate the durability of repigmentation.
Who has neurodermatitis / atopic dermatitis?
5 answers
Atopic dermatitis, also known as neurodermatitis or atopic eczema, is a common skin disease that often appears in early childhood. It is associated with tormenting itching and stigmatization, leading to an impaired quality of life. The disease initially manifests on the extensor sides of the extremities and later progresses to involve the flexor areas. In addition, a significant proportion of patients with atopic dermatitis develop associated respiratory diseases. Research has shown that children with atopic dermatitis experience increased sleep problems, including reduced sleep efficiency and duration, increased sleep fragmentation, and prolonged sleep onset latency. The severity of the disease directly influences the sleep quality. The pathogenesis of atopic dermatitis is multifactorial, involving genetic and environmental factors. Treatment focuses on preventing trigger factors, basic skin care, and the use of anti-inflammatory drugs during exacerbations. Early diagnosis and treatment are important to prevent sleep problems and adverse effects on children's well-being and development.
Who gets neurodermatitis / atopic dermatitis?
5 answers
Atopic dermatitis, also known as neurodermatitis, is a common skin disease that can affect both children and adults. It is characterized by itching and can have a significant impact on quality of life. The disease typically manifests in early childhood, with involvement of the extensor sides of the extremities. The pathogenesis of atopic dermatitis is multifactorial, involving genetic and environmental factors. Specific allergies, such as dust mite allergy and food allergy, may contribute to the development of the disease. There are two main subtypes of atopic dermatitis, IgE-associated and non-IgE-associated, with different prognoses for the development of respiratory diseases. Recent studies have shown that atopic dermatitis can also affect adults and have a negative impact on sleep, mental health, and quality of life. Overall, atopic dermatitis can affect individuals of all ages and is influenced by a combination of genetic, immunologic, and environmental factors.
What are the different pathways for B-cell differentiation?
5 answers
B-cell differentiation can occur through different pathways. One pathway involves the generation and maintenance of memory B-cell and plasma cell subsets during host defense, which is regulated by cytokine signaling and signal transducer and activator of transcription (STAT) signaling pathways. Another pathway involves the differentiation of memory B cells from the germinal center (GC) reaction, which is influenced by cellular and molecular factors. Additionally, B-cell differentiation can occur through extrafollicular (EF) responses, which have been implicated in autoimmune diseases like systemic lupus erythematosus (SLE). The metabolic demands of B-cell differentiation are regulated by B cell receptor signals, autophagy, mammalian target of rapamycin, and transcriptional control of transporters and enzymes. These pathways play distinct roles in B-cell survival, antibody production, and effector functions, depending on the fate of the B cell.